
U.S.-listed shares of cannabis firms jump in premarket trading
Trump considers reclassifying marijuana as less dangerous drug, the Wall Street Journal reported on Friday, citing people familiar with the matter
U.S.-listed Canopy Growth CGC.O surges 24.8%, Cronos Group CRON.O jumps 22.6% and Tilray Brands TLRY.O climbs 26.3%
SNDL SNDL.O and Aurora Cannabis ACB.O gain between 10.7% and 11.6%, respectively
Advisorshares Pure US Cannabis ETF MSOS.P jumped over 9.1%
Report says Trump, at a $1 million-per-plate fundraiser this month, told attendees he was interested in the change
Attendees include Trulieve CEO Kim Rivers, who urged Trump to pursue reclassification and expand medical marijuana research